Boardroom Alpha
Boardroom Alpha
WTW · Current Report (Form 8-K) · Filed January 9, 2026

Willis Towers Watson PLC — Current Report (Form 8-K)

Form
8-K
Filed
January 9, 2026
Period
Jan 7, 2026
Ticker
WTW
Accession
0001193125-26-009009
Boardroom Alpha · Filing insights

Willis Towers Watson enters a $775 million delayed-draw term loan facility to fund the Newfront Acquisition and refinance debt.

About Willis Towers Watson PLC
Market cap
$31.9B
1Y TSR
+4.4%
3Y TSR
+19.9%
Board grade
C-
Sector
Financial Services
CEO
Carl Aaron Hess
Last annual meeting: May 20, 2026 · View full Willis Towers Watson PLC profile →
8-K
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 7, 2026

 

 

Willis Towers Watson Public Limited Company

(Exact name of registrant as specified in its charter)

 

 

 

Ireland   001-16503   98-0352587

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

c/o Willis Group Limited, 51 Lime Street, London, EC3M 7DQ, England and Wales
(Address, including Zip Code, of Principal Executive Offices)

Registrant’s telephone number, including area code: (011) (44)-(20)-3124-6000

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Ordinary Shares, nominal value $0.000304635 per share   WTW   NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 1.01 Entry into a Material Definitive Agreement.

On January 7, 2026, Willis Towers Watson Public Limited Company (“WTW”), together with its wholly owned subsidiary, Trinity Acquisition plc, a limited company formed under the laws of England and Wales (“TA”) and TA’s indirect wholly owned subsidiary, Willis North America Inc., a Delaware corporation (“WNA” and together with TA, the “Borrowers”) entered into a $775,000,000 delayed draw term loan facility (the “Credit Facility”). The Credit Facility will mature on the date that is the earlier of (i) the third anniversary of the initial borrowing of loans under the Credit Facility and (ii) the third anniversary of the date that is two months after the consummation of the acquisition (the “Newfront Acquisition”) contemplated by that certain Agreement and Plan of Merger, dated as of December 9, 2025, by and among WNA, Napa Merger Sub Inc., Jonathan Young, as representative of the stockholders, Newfront Insurance Holdings, Inc. and the other parties thereto (the “Newfront Acquisition Agreement”). The terms of the Credit Facility are set forth in that certain Term Loan Credit Agreement, dated as of January 7, 2026 (the “Credit Agreement”), by and among the Borrowers (as defined in the Credit Agreement), WTW, as the parent, the lenders party thereto, and JPMorgan Chase Bank, N.A., as administrative agent.

The proceeds of the Credit Facility will be used (i) to finance a portion of the Newfront Acquisition, (ii) to refinance certain outstanding indebtedness of WTW and its subsidiaries, and (iii) for working capital, capital expenditures, permitted acquisitions and other lawful corporate purposes.

Amounts outstanding under the Credit Facility shall bear interest, at the Borrowers’ option, at a rate equal to (i) the Term SOFR rate plus an applicable margin of 0.625% to 1.250% (based upon WTW’s guaranteed senior-unsecured long term debt rating) or (ii) the base rate plus an applicable margin of 0.00% to 0.250% (based upon WTW’s guaranteed senior-unsecured long term debt rating). In addition, the Borrowers will pay a commitment fee in an amount equal to 0.055% to 0.140% (based upon WTW’s guaranteed senior-unsecured long term debt rating) on the unused amount of commitments under the Credit Facility.

The Credit Facility may be drawn in up to four borrowings during the period commencing on the date of the consummation of the Newfront Acquisition and ending on the earliest of (i) the Termination Date (as defined in the Newfront Acquisition Agreement, as it may be extended in accordance with Section 9.1(b) of the Newfront Acquisition Agreement as in effect on December 9, 2025), (ii) the date that is six months after the consummation of the Newfront Acquisition, (iii) the public announcement of the abandonment of the Newfront Acquisition by WTW, TA or any other Borrower, (iv) the termination of the Newfront Acquisition Agreement in accordance with its terms and (v) after the date of the fourth borrowing under the Credit Facility. Each borrowing under the Credit Facility is subject to customary conditions, including, solely in the case of drawings that are not used to fund the Newfront Acquisition, the accuracy and completeness in all material respects of all representations and warranties in the loan documentation and that no default under the Credit Facility shall exist, or would result from such borrowing or the application of the proceeds thereof.

Voluntary prepayment is permitted under the Credit Facility without penalty or premium in amounts greater than $5,000,000 or a whole multiple of $1,000,000 in excess thereof, or, if less, the entire principal amount thereof then outstanding.

WTW and its subsidiaries are subject to various affirmative and negative covenants and reporting obligations under the Credit Facility. These include, among others, limitations on indebtedness of non-loan parties, liens, certain investments, fundamental changes, sale of all or substantially all of the assets of WTW and its subsidiaries (on a consolidated basis), and maintenance of certain financial covenants. Events of default under the Credit Facility include non-payment of amounts due to the lenders, violation of covenants, incorrect representations, defaults under other material indebtedness, judgments and specified insolvency-related events, certain ERISA events, and invalidity of loan documents, subject to, in certain instances, specified thresholds, cure periods and exceptions. The obligations of the Borrowers under the Credit Facility are guaranteed by WTW and certain of its subsidiaries pursuant to that certain Guaranty Agreement, dated as of January 7, 2026 (the “Guaranty”), among TA, WTW, the other guarantors party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent. The obligations of the Borrowers under the Credit Facility are unsecured.

 

2


The description of the Credit Agreement does not purport to be complete and is qualified in its entirety by reference to the Credit Agreement, a copy of which is attached as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

Item 2.03

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information set forth in Item 1.01 above is incorporated by reference under this Item 2.03.

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit
Number
  

Description

10.1    Term Loan Credit Agreement, dated as of January 7, 2026, among Trinity Acquisition plc and its indirect subsidiary, Willis North America Inc., Willis Towers Watson Public Limited Company, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

3


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: January 9, 2026   WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY
        By:  

/s/ Andrew Krasner

      Andrew Krasner
      Chief Financial Officer

 

4

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Willis Towers Watson PLC (WTW)

Reference

Frequently asked questions

When did Willis Towers Watson PLC file this 8-K?
Willis Towers Watson PLC (WTW) filed this Current Report (Form 8-K) with the SEC on January 9, 2026. The accession number assigned by EDGAR is 0001193125-26-009009.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Willis Towers Watson enters a $775 million delayed-draw term loan facility to fund the Newfront Acquisition and refinance debt. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Willis Towers Watson PLC's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Willis Towers Watson PLC has filed under CIK 1140536, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer